Syndax Pharmaceuticals Q1 EPS $(0.48) Beats $(0.64) Estimate, Sales $64.864M Miss $70.439M Estimate
Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.64) by 25 percent. This is a 51.02 percent increase over losses of $(0.98) per share
